1736-21-6 Usage
General Description
3-(4-Fluorophenyl)-5-methyl-4-isoxazolecarboxylic acid is a chemical compound with the molecular formula C11H8FNO3. It is a derivative of isoxazolecarboxylic acid, and it contains a fluorophenyl and methyl group attached to the isoxazole ring. 3-(4-FLUOROPHENYL)-5-METHYL-4-ISOXAZOLECARBOXYLIC ACID is used in the pharmaceutical industry as a building block for the synthesis of various drugs and pharmaceutical compounds. It has also shown potential for activity against certain biological targets, such as enzymes or receptors, making it valuable for medicinal chemistry research. Additionally, it has been investigated for its potential anti-inflammatory and analgesic properties, making it a compound of interest for the development of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1736-21-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,3 and 6 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1736-21:
(6*1)+(5*7)+(4*3)+(3*6)+(2*2)+(1*1)=76
76 % 10 = 6
So 1736-21-6 is a valid CAS Registry Number.
InChI:InChI=1/C11H8FNO3/c1-6-9(11(14)15)10(13-16-6)7-2-4-8(12)5-3-7/h2-5H,1H3,(H,14,15)
1736-21-6Relevant articles and documents
(1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV
-
, (2014/10/29)
The invention relates to an administration unit comprising a compound of formula and/or pharmaceutically acceptable salts thereof, and to a packaging comprising the administration unit according to the invention.
PROCESS FOR THE PREPARATION OF ISOXAZOLYL- METHOXY NICOTINIC ACIDS
-
Paragraph 0221, (2013/05/08)
The present invention relates to a process for the preparation of a compound of formula (I) wherein R1 and R2 are as defined herein, which is useful as an intermediate in the preparation of active pharmaceutical compounds.
NOVEL SOLID FORMS
-
Paragraph 0258, (2013/07/19)
The instant invention relates to novel solid forms of the compound of formula (I) as well as solvates, inclusion complexes with other suitable compounds, processes for their manufacture, pharmaceutical compositions containing these solid forms, and their